DCTH vs RCEL: stock comparison and AI forecast
Delcath Systems, Inc. (DCTH) and Avita Medical, Inc. (RCEL) compared on price performance, valuation, profitability and the daily AI forecast. · Alpha · vs market
Share
DCTH Delcath Systems, Inc.
- Market Cap
- $496M
- P/E Ratio
- 200.6x
- Size
- small-cap
- AI Forecast
- NO CURRENT FORECAST
RCEL Avita Medical, Inc.
- Price
- $15.41 +260.0% · 6M
- Market Cap
- $474M
- P/E Ratio
- –
- Size
- small-cap
- AI Forecast
Which one does the AI model favor?
Intratio's model scores both stocks every trading day. Sign in to see their current direction; the exact ratings and forecasts come with a plan or a free follow slot.
Key facts
- DCTH and RCEL have similar market capitalizations ($496M and $474M).
- DCTH turns 0.6% of its revenue into net income, against -57.0% for RCEL.
- Both companies share the SEC industry classification Surgical & Medical Instruments & Apparatus.
Fundamentals side by side
Trailing twelve months.
Valuation & Market
| Metric | DCTH | RCEL |
|---|---|---|
| Market Cap | $496M | $474M |
| P/E Ratio | 200.55x | – |
| P/B Ratio | 4.09x | – |
| EPS | $0.07 | $-1.61 |
| Book Value/Share | $3.43 | – |
| Revenue/Share | $2.70 | $2.45 |
| FCF/Share | $0.50 | $-0.80 |
Profitability & Margins
| Metric | DCTH | RCEL |
|---|---|---|
| ROE | 0.4% | – |
| ROA | 0.4% | -90.2% |
| ROIC | -1.5% | 168.2% |
| Gross Margin | 87.0% | 81.6% |
| Operating Margin | -1.9% | -46.6% |
| Net Margin | 0.6% | -57.0% |
| EBT Margin | 1.4% | -56.9% |
| Tax Rate | 58.8% | -0.1% |
Financial Health
| Metric | DCTH | RCEL |
|---|---|---|
| Current Ratio | 9.83x | 0.41x |
| Quick Ratio | 8.95x | 0.34x |
| D/E Ratio | 0.13x | – |
| Financial Leverage | 1.13x | – |
| Interest Coverage | 13.7x | -4.7x |
| Working Capital | $117M | -$40M |
Cash Flow
| Metric | DCTH | RCEL |
|---|---|---|
| Operating Cash Flow | $20M | -$24M |
| Free Cash Flow | $18M | -$25M |
| Capital Spending | -$2M | -$390K |
| OCF Growth YoY | 303.9% | – |
| FCF Growth YoY | 352.7% | – |
| FCF/Sales | 18.4% | -32.5% |
| CapEx/Sales | 2.2% | 0.5% |
Operational Efficiency
| Metric | DCTH | RCEL |
|---|---|---|
| Asset Turnover | 0.70x | 1.58x |
| Receivables Turnover | 6.0x | 7.7x |
| Inventory Turnover | 1.1x | 2.6x |
| Fixed Assets Turnover | 23.7x | 9.8x |
| Days Sales Outstanding | 61 days | 48 days |
| Days Inventory | 346 days | 138 days |
| Payables Period | 118 days | – |
| Cash Conversion Cycle | 289 days | – |
Income Statement
| Metric | DCTH | RCEL |
|---|---|---|
| Total Revenue | $95M | $76M |
| Operating Income | -$2M | -$35M |
| Net Income | $530K | -$43M |
| R&D Expense | $38M | $20M |
| SG&A Expense | $47M | $90M |
| Cost of Goods Sold | $12M | $14M |
Dividend & Shareholder Information
| Metric | DCTH | RCEL |
|---|---|---|
| Shares Outstanding | 35M | 31M |
| Net Income Growth | -76.2% | – |
DCTH vs RCEL: stock comparison and AI forecast
Which is bigger, DCTH or RCEL?
DCTH and RCEL have similar market capitalizations ($496M and $474M).
Which one does Intratio's AI model rank higher, DCTH or RCEL?
Intratio's model scores both stocks every trading day. Sign in to see their current direction; the exact ratings and forecasts come with a plan or a free follow slot.
More comparisons
This analysis is generated automatically using our proprietary AI systems and should not be considered personalized investment advice. Past performance does not guarantee future results. Always conduct your own research and consider consulting a financial advisor before making investment decisions.